<DOC>
	<DOCNO>NCT01448603</DOCNO>
	<brief_summary>Ragweed primary cause autumn allergy . The ragweed season begin mid-August . In third National Health Nutrition Examination Surveys54.3 % population positive test responses one allergen , prevalence short ragweed 26.2 % The purpose observational follow-on study evaluate rhinoconjunctivitis symptom exposure ragweed allergen EEC among subject complete dose visit post treatment challenge ( PTC ) visit study TR002 approximately one year start treatment .</brief_summary>
	<brief_title>ToleroMune Ragweed Follow Study</brief_title>
	<detailed_description>Subjects randomise study TR002 complete dose visit PTC invite attend Screening Visit TR002B . Subjects attend EEC 4 visit successive day . Following final EEC visit follow-up visit perform 3-10 day later .</detailed_description>
	<criteria>Inclusion Criteria Previously randomise study TR002 complete treatment visit PTC . Exclusion Criteria History asthma ( diagnosis asthma childhood may allow ) . Subjects FEV1 &lt; 70 % predict . Subjects treat betablockers . Developed significant disease , disorder inability communicate , since complete study TR002 , opinion Sponsor 's medical representative , may either put subject risk participation study , influence result study , subject 's ability participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Ragweed allergy</keyword>
	<keyword>ToleroMune ragweed</keyword>
	<keyword>immunotherapy</keyword>
</DOC>